Take advantage of Inotiv's extensive experience across the biological continuum supporting a full spectrum of biotherapeutics and biomarkers, from discovery to Phase IV clinical studies. Our bioanalytical capabilities for biotherapeutics include:
- Discovery PK/PD of biotherapeutics
- Preclinical and clinical regulated programs
- PK/TD/PD analysis
- Immunogenicity assessment chemiluminescence assays
- Receptor occupancy assays
- Bioequivalence studies
- Biosimilars and biobetters
- Immunophenotyping
- Cell and gene therapy
- Vaccines
- Biomarkers
- Tissue analysis
- Multiple biological matrices
Complete the form to speak to an expert.
